Company / Operating Income per Share
MADRIGAL PHARMACEUTICALS, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$13.64
FY2025
5-year range
-$25.05 / -$13.64
FY2021-FY2025
Trend
+45.6%
vs FY2024
Sector context
#196 of 201
Health Care
What the data says
Among 201 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the bottom 2% for operating income per share. Operating Income per Share returned to growth in FY2025 after 7 years of decline, reaching $-13.64.
Based on SEC 10-K filings.
-13.64 in FY2025.
Improved from $-21.02 to $-13.64 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 201This company -$13.64 Sector average -$28.56
▼
+52.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 45.6% year-over-year.
- Ranks #196 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$13.64 | +45.6% |
| FY2024 | -$25.05 | -19.2% |
| FY2023 | -$21.02 | -22.7% |
| FY2022 | -$17.13 | -9.6% |
| FY2021 | -$15.64 | -16.7% |
| FY2020 | -$13.39 | -117.1% |
| FY2019 | -$6.17 | -124.4% |
| FY2018 | -$2.75 | -5.0% |
| FY2017 | -$2.62 | +46.0% |
| FY2016 | -$4.85 | -392.0% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026